Your location:Home - News - Industry dynamics
Reprint:For the first time, domestic high-end medical equipment has been exported in reverse
Release time:2025-07-25 10:41:27      Clicks:798

Breaking the 30-year monopoly of Europe and America, domestic high-end medical equipment has been exported in reverse for the first time and has obtained FDA certification!

Just now, the domestically developed intracardiac ultrasound system was approved by the US FDA!

Finally, our domestic medical devices have a high-end device that has truly opened the door to the world's most demanding medical market!

The intracardium ultrasound (ICE) system independently developed by Tingsheng Technology has officially been approved by the US FDA (K Number: K250913)!


This means that top-notch cardiac interventional imaging equipment made in China has for the first time taken center stage on the world stage, completely reversing the historical situation where high-end cardiac ultrasound equipment could only be imported but not exported! This is not only a milestone for Tingsheng Technology, but also a moment when the entire Chinese medical device industry can hold its head high!

01 Why? Is this set of "Chinese Heart" equipment really that hardcore?


The ICE system of Tingsheng that successfully passed the FDA this time relies on two solid "hard nuclear weapons" :

  • First of all, there is TINGSN FINDERS 2. You can understand it as the "intelligent brain" of the entire system. It is a portable color Doppler ultrasound diagnostic instrument. It is small in size but has considerable capabilities. It is equipped with a high-definition imaging platform and intelligent analysis algorithms, capable of providing very clear and accurate cardiac imaging data. Doctors use it to examine the structure of the heart as if it were in "high definition mode".


  • Then there is TINGSN Sonic Eyes 10 Eco, which is the "reconnaissance sharpshooter" that penetrates deep into the heart. This is a very thin intracardiac ultrasound diagnostic catheter with a diameter of only 10F. It is exquisitely designed and can be directly delivered into the heart through blood vessels. During the operation, it can "live-stream" the internal structure and blood flow of the heart in real time and dynamically, providing precise "visual navigation" for doctors to perform interventional surgeries (such as atrial fibrillation ablation), making the operation safer and more effective.


Since its establishment in 2017, Tingsheng Technology has been committed to one direction: to create excellent products in the fields of cardiac electrophysiology and structural heart disease with innovative ultrasound technology. What they are thinking about is how to better integrate core technologies such as imaging, mapping (locating lesions), and ablation energy, ultimately enabling more patients with heart disease to receive more effective treatment.

After several years of hard work, Tingsheng has made consecutive breakthroughs in ICE technology. Their ICE system, with core advantages such as image clarity comparable to top imported products, simple and convenient operation, and extremely stable performance, has not only quickly established a firm foothold in the domestic market and won a good reputation among doctors, but has now made a stunning debut, becoming the world's first domestic ICE product to obtain FDA certification!

This heavy FDA certification stamp is the highest recognition from international authorities of China's R&D capabilities in high-end medical devices!

02Here comes the game-changer! From now on, the "Chinese voice" can be heard in the market worth hundreds of billions.

What was the situation of the global ICE market before Tingsheng's rise?

For a long time, this field with extremely high technical barriers has been firmly controlled by a few European and American giants, almost monopolizing it. Domestic hospitals in our country have to spend a lot of money to purchase imported equipment if they want to use ICE. Not only is the cost high, but the options are also pitifully limited. The feeling of being controlled by others in core technologies is not pleasant.


Data shows that the global ICE market size has exceeded one billion US dollars in 2024 and is still growing at a high speed! This huge cake used to have little to do with China. This breakthrough by Tingsheng Technology is like a sharp "scalpel", taking the lead in cutting through this solid monopoly barrier!

Its significance is far more than just having an additional supplier: doctors can finally no longer rely solely on imported equipment and have domestic alternatives that are superior in performance and more in line with their needs. Especially in terms of cost control, it can effectively reduce medical costs. The rise of domestic high-end equipment will inevitably bring about more healthy market competition, help reduce the overall cost of equipment and surgery, and ultimately benefit patients and the national medical insurance.

With the FDA certification, Tingsheng has demonstrated to the world that high-end medical devices made in China are fully capable of matching or even surpassing the world's top level in terms of core performance and quality! Shattering the old notion that "domestic products are inferior to imported ones" has greatly boosted the confidence of the entire industry.

China's high-end medical equipment is no longer a "runner-up", but a "powerful player" capable of reshaping the global market landscape!

03FDA Certification: The "Golden Pass" for the Global Market, the best endorsement for "Made in China".

Everyone in the medical device industry knows that the certification standards of the US FDA are notoriously strict and can be regarded as the "golden pass" and "highest safety certification" in the global market. How many products have failed at this threshold?


The fact that the Tingsheng ICE system has successfully obtained the FDA's "pass" indicates that after the FDA's experts reviewed it with the most critical eyes, they confirmed that the Tingsheng ICE system is safe and effective, fully meeting the strict requirements of the US market.

The obstacles to entering the world's largest single medical market have been cleared: The United States is the world's largest consumer of medical devices. Obtaining FDA certification is equivalent to getting the ticket to enter this largest and most high-end market, and the path to going global has suddenly become clear.

Setting a new benchmark for Chinese medical devices to "go global" is not only an honor for Tingsheng alone, but also a landmark event in the internationalization process of China's medical device industry! It powerfully declares to the global market that Chinese medical technology enterprises have already possessed world-class innovation capabilities and product strength!

The starting point, not the end: The vast ocean of the Chinese "heart"

Obtaining FDA certification is the best reward for the Tingsheng team's years of commitment to independent research and development and their spirit of tackling tough problems. It is also a crucial leap for China's intracardiac ultrasound technology to truly step onto the global stage!

But this is merely the beginning.

Note: The above content is for reference only and does not constitute investment advice. The relevant interpretations of official policies in this article only represent the views of this platform. The content is subject to official documents.

Last:Reprint:From "running to the city" to "getting things done at home"
Next:Reprint:Laparoscopic minimally invasive technology helps you "reduce"

Return